|
|
||||
|
BioShield outlined
Email: Ted Agres - tedagres@lycos.com News from The Scientist 2003, 4(1):20030204-03 doi:10.1186/20030204-03
|
||||
|
|
||||
|
Project BioShield, a 10-year $6-billion program to develop and produce new vaccines and countermeasures against potential bioweapons, would give the National Institutes of Health (NIH) new authority to bypass traditional procedures when awarding urgently-needed research and development grants and contracts and allow the Food and Drug Administration (FDA) to distribute experimental drugs in case of a bioterrorist attack or other emergency.
|
|
|||||||||
|
|||||||||
|